The efficiency and safety of anti-Helicobacter pylori therapy in patients with concomitant chronic hepatitis C

The efficiency and safety of anti-Helicobacter pylori therapy in patients with concomitant chronic hepatitis C

Aim. To evaluate the efficiency and safety of two eradication therapy (ET) regimens for Helicobacter pylori infection in patients with concomitant chronic hepatitis C (CHC) in relation to the stage of liver fibrosis (LF). Subjects and methods. A prospective clinical trial was conducted in parallel g...

Full description

Bibliographic Details
Main Authors:	D N Andreev, I V Maev, Yu A Kucheryavyi, D T Dicheva, E V Partsvania-vinogradova
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2016-04-01
Series:	Терапевтический архив
Subjects:	helicobacter pylori peptic ulcer hcv hepatitis c liver fibrosis liver cirrhosis anti-helicobacter pylori therapy adverse events
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/31983/pdf

Similar Items

Evaluation of efficacy and safety of rebamipide use in the triple therapy for Helicobacter pylori eradication: a pilot study
by: D. T. Dicheva, et al.
Published: (2018-04-01)

Helicobacter pylori y enfermedad péptica ulcerosa
by: Noel Padrón Pérez, et al.
Published: (1998-12-01)

Frequency of Helicobacter pylori infection in patients with liver cirrhosis
by: Alempijević Tamara, et al.
Published: (2007-01-01)

Helicobacter pylori-negative Peptic Ulcer
by: Ji Hyun Song, et al.
Published: (2017-09-01)

Clinically-Endoscopic Manifestations of Peptic Ulcer disease in Children Depending on Helicobacter pylori Infection
by: Т.V. Sorokman, et al.
Published: (2014-04-01)

Saliva Secretion and Efficacy of Helicobacter Pylori Eradication in Peptic Ulcer Patients
by: M. Vahedi, et al.
Published: (2011-12-01)

Diagnostic Accuracy of Serology Testing for Helicobacter Pylori in Perforated Peptic Ulcer
by: Syed Abbas Ali Shah
Published: (2014-12-01)

Helicobacter pylori in gastroduodenal perforation
by: Bharat B Dogra, et al.
Published: (2014-01-01)

Outpatient ronkoleukin treatment of gastric ulcer associated with Helicobacter pylori
by: Tat'yana Aleksandrovna Smipnova, et al.
Published: (2009-02-01)

Infeksi Helicobacter pylori /
by: 558487 Sabiha Pit
Published: (2005)

Prevalence of Helicobacter pylori infection in patients with chronic hepatitis C
by: Abdelfattah M. Attallah, et al.
Published: (2022-01-01)

Neither genotype nor the gastric colonization site of Helicobacter pylori are predictive factors for the development of erosive esophagitis in patients with peptic ulcer disease, 1 year after eradication O genótipo e o local no estômago de isolamento do Helicobacter pylori em pacientes com úlcera péptica não são fatores preditivos para o desenvolvimento de esofagite erosiva 1 ano após a erradicação da bactéria
by: Carlos Alexandre Gonçalves Batista, et al.
Published: (2009-09-01)

Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection
by: G L Yurenev, et al.
Published: (2018-08-01)

Pattern of Helicobacter pylori Antigens Isolated from Patients with Peptic Ulcer by Immunoblotting
by: Jalil Tavakkol Afshari, et al.
Published: (2003-03-01)

Efeito da administração de vitamina C sobre a colonização do estômago por Helicobacter pylori Effect of vitamin C administration on gastric colonization by Helicobacter pylori
by: Mayra Mayumi Kamiji, et al.
Published: (2005-09-01)

Nursing care for peptic ulcer patients following the nursing process
by: Radulović Vedrana, et al.
Published: (2019-01-01)

The significance of chronic hyperglycemia for the reduced efficacy of eradication therapy in patients with type 2 diabetes mellitus and for Helicobacter pylori survival
by: Luiza Gilmanovna Bektemirova, et al.
Published: (2023-12-01)

Frequency of H. pylori in liver cirrhosis patients with overt Hepatic encephalopathy at tertiary care hospital, Karachi.
by: Shaista Ahmed, et al.
Published: (2022-07-01)

Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
by: Eman T. Azab, et al.
Published: (2022-06-01)

Peptic Ulcer Disease Associated with Helicobacter pylori Infection
by: Se-Hwan Yeo, et al.
Published: (2016-06-01)

The state of intestinal microbiocenosis in children with Helicobacter pylori-associated duodenal ulcer
by: T.V. Sorokman, et al.
Published: (2021-04-01)

Clinical and morphological characteristics of portal gastropathy in patients with liver cirrhosis
by: Vladislav Vladimirovich Tsukanov, et al.
Published: (2010-02-01)

Helicobacter Pylori Positivity in Patients with Hyperemesis Gravidarum
by: Emel Ebru Özçimen, et al.
Published: (2006-12-01)

Association between Helicobacter pylori infection and cirrhosis in children
by: Mozhgan Zahmatkeshan, et al.
Published: (2019-09-01)

Tratamiento de la infección por Helicobacter pylori: Comentario al respecto
by: Noel Padrón Pérez, et al.
Published: (1999-12-01)

Characteristics of Helicobacter pylori Heteroresistance in Gastric Biopsies and Its Clinical Relevance
by: You-hua Wang, et al.
Published: (2022-02-01)

Effect of Helicobacter pylori infection and acid blockade by lansoprazole on clarithromycin bioavailability
by: R.A.M. Ortiz, et al.
Published: (2007-03-01)

Role of Helicobacter pylori eradication in the prevention of gastric cancer
by: V V Tsukanov, et al.
Published: (2014-08-01)

The prevalence of Helicobacter pylori infection among urban population
by: T V Zhestkova, et al.
Published: (2018-04-01)

Infección por Helicobacter pylori en pacientes con mucosa sana y con gastritis erosiva Helicobacter pylori infection present in patients with a healthy mucosa and erosive gastritis
by: María Teresa Martínez Echavarría, et al.
Published: (2009-06-01)

Invitro Comparitive Study of the Efficacy of Licorice Decoctant and Choice Antibiotics on Helicobacter Pylori Growth
by: Z Botorabi, et al.
Published: (2005-07-01)

Pharmacoepidemiology of peptic ulcer in Smolensk: 15 years later
by: Dekhnich N.N., et al.
Published: (2019-10-01)

Proinflammatory cytokines and thrombomodulin in patients with peptic ulcer disease and gastric cancer, infected with Helicobacter pylori
by: Mehrdad Haghazali, et al.
Published: (2011-01-01)

Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori
by: Tariq H, et al.
Published: (2020-01-01)

¿Sabía usted? Infección por helicobacter pylori
by: Federico Díaz González
Published: (1993-02-01)

Diagnóstico serológico de Helicobacter pylori en pacientes con síntomas digestivos
by: Amilcar Duquesne Alderete, et al.
Published: (2019-01-01)

Immunological and morphological aspects of diagnostics of Helicobacter pylori infection and Herpesviridae viruses
by: N.G. Dudaeva, et al.
Published: (2010-06-01)

Role of Helicobacter pylori in Rosacea
by: Nazan EMİROĞLU, et al.
Published: (2018-01-01)

Trends in peptic ulcer disease and the identification of Helicobacter Pylori as a causative organism: Population-based estimates from the US nationwide inpatient sample
by: Bronislava Bashinskaya, et al.
Published: (2011-01-01)

Comparison of Serum Gastrin Level with Anti–Helicobacter Pylori Antibody in Helicobacter Pylori Infected Patients with and without Peptic Ulcer
by: Mohammadi S, Firouzjahi AR, Shokri Shirvani J, Bijani A
Published: (2011-09-01)